Objectives: There is clear evidence that pharmacotherapy improves survival and reduces hospitalisation due to heart failure; however, medication adherence is sub-optimal. The purpose of this review was to establish which interventions are effective in enhancing medication adherence in patients with chronic heart failure.Design, Methods, and Results: We conducted a systematic review of randomized controlled trials searching for all-language publications in electronic databases (MEDLINE, CINAHL, Embase, Cochrane Central Register of Controlled Trials, and PsycINFO) to the end of March 2015. Trials describing interventions intended to enhance adherence to self-administered medications in the treatment of heart failure were eligible. Two indepen...
Publisher's Version/PDFBackground Successful management of cardiovascular disease (CVD) is impaired...
Background Nonadherence to cardiovascular medicines occurs in 60% of subjects with chronic cardiovas...
Work supported by Medical Research Council (MRC) [MR/N013166/1 to K.H.L.]Background: Use of cardiova...
Objectives: There is clear evidence that pharmacotherapy improves survival and reduces hospitalisati...
© 2016 John Wiley & Sons Ltd Aims: The aim of this study was to critically appraise and synthesize t...
Heart failure is a chronic disease that increases mortality, reduces quality of life, and increases ...
Prognosis remains poor for patients with chronic heartfailure (CHF), despite improvements in the pre...
Background: Because of the improvement of the pharmacological and non-pharmacological treatment in h...
To determine and address medication non-adherence is important and may improve patient outcomes. Our...
To determine and address medication non-adherence is important and may improve patient outcomes. Our...
OBJECTIVE: To determine the optimal modes of delivery for interventions to improve adherence to card...
Background: Use of cardiovascular medication has increased over time, especially for primary and sec...
BACKGROUND: Adherence to multiple cardiovascular (CV) medications is a cornerstone of coronary heart...
OBJECTIVE: To evaluate and compare the effect of interventions for improving adherence to medication...
Introduction: Heart failure (HF) guidelines aim to standardise patient care. Internationally, prescr...
Publisher's Version/PDFBackground Successful management of cardiovascular disease (CVD) is impaired...
Background Nonadherence to cardiovascular medicines occurs in 60% of subjects with chronic cardiovas...
Work supported by Medical Research Council (MRC) [MR/N013166/1 to K.H.L.]Background: Use of cardiova...
Objectives: There is clear evidence that pharmacotherapy improves survival and reduces hospitalisati...
© 2016 John Wiley & Sons Ltd Aims: The aim of this study was to critically appraise and synthesize t...
Heart failure is a chronic disease that increases mortality, reduces quality of life, and increases ...
Prognosis remains poor for patients with chronic heartfailure (CHF), despite improvements in the pre...
Background: Because of the improvement of the pharmacological and non-pharmacological treatment in h...
To determine and address medication non-adherence is important and may improve patient outcomes. Our...
To determine and address medication non-adherence is important and may improve patient outcomes. Our...
OBJECTIVE: To determine the optimal modes of delivery for interventions to improve adherence to card...
Background: Use of cardiovascular medication has increased over time, especially for primary and sec...
BACKGROUND: Adherence to multiple cardiovascular (CV) medications is a cornerstone of coronary heart...
OBJECTIVE: To evaluate and compare the effect of interventions for improving adherence to medication...
Introduction: Heart failure (HF) guidelines aim to standardise patient care. Internationally, prescr...
Publisher's Version/PDFBackground Successful management of cardiovascular disease (CVD) is impaired...
Background Nonadherence to cardiovascular medicines occurs in 60% of subjects with chronic cardiovas...
Work supported by Medical Research Council (MRC) [MR/N013166/1 to K.H.L.]Background: Use of cardiova...